Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 14 | 2024 | 2355 | 2.240 |
Why?
|
Thyroid Hormone Resistance Syndrome | 3 | 2021 | 15 | 1.940 |
Why?
|
Thyroid Hormone Receptors beta | 3 | 2021 | 21 | 1.500 |
Why?
|
Thyroid Nodule | 4 | 2024 | 765 | 1.240 |
Why?
|
Thyrotropin | 6 | 2024 | 834 | 1.190 |
Why?
|
Hypothyroidism | 4 | 2021 | 667 | 1.010 |
Why?
|
Renal Plasma Flow | 1 | 2021 | 27 | 0.770 |
Why?
|
Inheritance Patterns | 2 | 2021 | 344 | 0.750 |
Why?
|
Thyroid Gland | 5 | 2024 | 1170 | 0.740 |
Why?
|
Iodine Radioisotopes | 2 | 2024 | 1029 | 0.740 |
Why?
|
Thyroid Hormones | 5 | 2018 | 408 | 0.700 |
Why?
|
Adrenal Glands | 2 | 2011 | 557 | 0.620 |
Why?
|
Gonadal Steroid Hormones | 2 | 2012 | 707 | 0.580 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2016 | 228 | 0.560 |
Why?
|
Aldosterone | 7 | 2015 | 881 | 0.550 |
Why?
|
Mutation | 10 | 2024 | 30211 | 0.530 |
Why?
|
Carcinoma, Medullary | 2 | 2016 | 115 | 0.520 |
Why?
|
Hyperthyroxinemia, Familial Dysalbuminemic | 1 | 2015 | 1 | 0.520 |
Why?
|
Thyroxine-Binding Proteins | 1 | 2015 | 24 | 0.520 |
Why?
|
Thyrotropin, beta Subunit | 1 | 2015 | 4 | 0.510 |
Why?
|
Postmenopause | 4 | 2014 | 2518 | 0.480 |
Why?
|
Adrenal Gland Neoplasms | 5 | 2015 | 733 | 0.480 |
Why?
|
Adrenocortical Adenoma | 2 | 2012 | 46 | 0.470 |
Why?
|
Euthyroid Sick Syndromes | 2 | 2010 | 14 | 0.440 |
Why?
|
Hyperthyroidism | 2 | 2020 | 292 | 0.430 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2012 | 161 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2457 | 0.400 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2058 | 0.400 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2061 | 0.390 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2883 | 0.380 |
Why?
|
Biopsy, Fine-Needle | 5 | 2024 | 1131 | 0.380 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2744 | 0.360 |
Why?
|
Sepsis | 1 | 2024 | 2605 | 0.350 |
Why?
|
Hyperaldosteronism | 4 | 2015 | 252 | 0.350 |
Why?
|
Prenatal Diagnosis | 1 | 2017 | 1271 | 0.350 |
Why?
|
Hypokalemic Periodic Paralysis | 1 | 2010 | 7 | 0.350 |
Why?
|
Thyroxine | 3 | 2020 | 666 | 0.330 |
Why?
|
Estrogen Receptor alpha | 1 | 2013 | 581 | 0.320 |
Why?
|
Thyroid Function Tests | 3 | 2021 | 289 | 0.310 |
Why?
|
Acromegaly | 1 | 2011 | 315 | 0.300 |
Why?
|
Pituitary Neoplasms | 3 | 2014 | 1322 | 0.300 |
Why?
|
Stroke | 5 | 2013 | 9746 | 0.290 |
Why?
|
Hydrocortisone | 7 | 2015 | 1840 | 0.280 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2299 | 0.280 |
Why?
|
Arteries | 1 | 2012 | 1123 | 0.270 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2972 | 0.270 |
Why?
|
Human Growth Hormone | 1 | 2011 | 642 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1478 | 0.240 |
Why?
|
Triiodothyronine | 4 | 2020 | 493 | 0.240 |
Why?
|
Estradiol | 1 | 2012 | 1951 | 0.240 |
Why?
|
Hypertension | 6 | 2015 | 8615 | 0.230 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2971 | 0.220 |
Why?
|
Enhancer Elements, Genetic | 2 | 2024 | 1366 | 0.220 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1883 | 0.210 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2024 | 361 | 0.210 |
Why?
|
Microsatellite Repeats | 1 | 2024 | 784 | 0.190 |
Why?
|
Hypertension, Renal | 1 | 2021 | 135 | 0.190 |
Why?
|
Ultrasonography | 3 | 2024 | 6000 | 0.190 |
Why?
|
Humans | 54 | 2024 | 767040 | 0.180 |
Why?
|
Propylthiouracil | 1 | 2020 | 68 | 0.180 |
Why?
|
Leukocyte Count | 1 | 2024 | 1606 | 0.180 |
Why?
|
Antithyroid Agents | 1 | 2020 | 72 | 0.180 |
Why?
|
Mental Retardation, X-Linked | 1 | 2020 | 42 | 0.180 |
Why?
|
Watchful Waiting | 1 | 2024 | 492 | 0.170 |
Why?
|
Iodide Peroxidase | 1 | 2021 | 295 | 0.170 |
Why?
|
Diet, Sodium-Restricted | 1 | 2021 | 291 | 0.160 |
Why?
|
Fetal Therapies | 1 | 2020 | 101 | 0.160 |
Why?
|
Chromogranins | 1 | 2020 | 160 | 0.160 |
Why?
|
Muscle Hypotonia | 1 | 2020 | 166 | 0.160 |
Why?
|
Female | 36 | 2024 | 396660 | 0.160 |
Why?
|
Heterozygote | 2 | 2016 | 2794 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18063 | 0.150 |
Why?
|
Prognosis | 6 | 2023 | 29963 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 194 | 0.150 |
Why?
|
Carcinoma, Papillary | 1 | 2023 | 791 | 0.150 |
Why?
|
Male | 29 | 2024 | 364203 | 0.150 |
Why?
|
Hemodynamics | 2 | 2021 | 4186 | 0.140 |
Why?
|
Severity of Illness Index | 6 | 2013 | 15925 | 0.140 |
Why?
|
Muscular Atrophy | 1 | 2020 | 335 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2021 | 703 | 0.140 |
Why?
|
Middle Aged | 27 | 2024 | 223233 | 0.140 |
Why?
|
Adult | 22 | 2024 | 223317 | 0.140 |
Why?
|
Aged | 19 | 2024 | 171319 | 0.120 |
Why?
|
Thyroxine-Binding Globulin | 1 | 2015 | 1 | 0.120 |
Why?
|
Diazoxide | 1 | 2015 | 52 | 0.120 |
Why?
|
Pedigree | 3 | 2024 | 4539 | 0.120 |
Why?
|
Pakistan | 1 | 2015 | 299 | 0.110 |
Why?
|
Ergolines | 1 | 2014 | 55 | 0.110 |
Why?
|
Calcitonin | 1 | 2015 | 328 | 0.110 |
Why?
|
Optic Chiasm | 1 | 2014 | 91 | 0.110 |
Why?
|
Obesity | 2 | 2013 | 13085 | 0.110 |
Why?
|
DNA-Cytosine Methylases | 1 | 2013 | 17 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2013 | 4054 | 0.110 |
Why?
|
Prolactinoma | 1 | 2014 | 114 | 0.110 |
Why?
|
Consanguinity | 1 | 2015 | 460 | 0.110 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 1743 | 0.100 |
Why?
|
Encephalocele | 1 | 2014 | 135 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2024 | 81659 | 0.100 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2013 | 766 | 0.100 |
Why?
|
Hyperinsulinism | 1 | 2015 | 402 | 0.100 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2014 | 164 | 0.100 |
Why?
|
Prospective Studies | 5 | 2022 | 54886 | 0.100 |
Why?
|
Glycine | 1 | 2015 | 670 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2326 | 0.100 |
Why?
|
Adrenal Cortex | 1 | 2012 | 134 | 0.090 |
Why?
|
Arginine | 1 | 2015 | 931 | 0.090 |
Why?
|
Androstenedione | 1 | 2011 | 132 | 0.090 |
Why?
|
Dopamine Agonists | 1 | 2014 | 346 | 0.090 |
Why?
|
Genotype | 2 | 2017 | 13035 | 0.090 |
Why?
|
Radioimmunoassay | 1 | 2011 | 861 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59548 | 0.090 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2011 | 241 | 0.090 |
Why?
|
Homozygote | 1 | 2015 | 1774 | 0.090 |
Why?
|
Incidental Findings | 2 | 2012 | 698 | 0.080 |
Why?
|
Pituitary Diseases | 1 | 2011 | 137 | 0.080 |
Why?
|
Insulinoma | 1 | 2010 | 121 | 0.080 |
Why?
|
Azathioprine | 1 | 2011 | 354 | 0.080 |
Why?
|
Case-Control Studies | 7 | 2020 | 22254 | 0.080 |
Why?
|
Birth Weight | 1 | 2017 | 2122 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2012 | 542 | 0.080 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1181 | 0.080 |
Why?
|
Adrenalectomy | 1 | 2010 | 347 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2017 | 2592 | 0.070 |
Why?
|
MicroRNAs | 1 | 2024 | 3792 | 0.070 |
Why?
|
Hypoglycemia | 1 | 2015 | 896 | 0.070 |
Why?
|
Protein Conformation | 1 | 2015 | 3948 | 0.070 |
Why?
|
Mothers | 1 | 2017 | 2209 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11657 | 0.070 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9245 | 0.070 |
Why?
|
Signal Transduction | 2 | 2021 | 23621 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15645 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3621 | 0.060 |
Why?
|
Fatty Liver | 1 | 2012 | 811 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6360 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2011 | 2920 | 0.060 |
Why?
|
Genetic Testing | 2 | 2016 | 3591 | 0.060 |
Why?
|
Cohort Studies | 3 | 2021 | 41718 | 0.060 |
Why?
|
Osteoporosis | 1 | 2015 | 1604 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4903 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5388 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39317 | 0.060 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 584 | 0.060 |
Why?
|
Young Adult | 8 | 2021 | 59980 | 0.060 |
Why?
|
Body Mass Index | 4 | 2022 | 13048 | 0.060 |
Why?
|
Prevalence | 4 | 2015 | 15851 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2030 | 0.060 |
Why?
|
Vitamin D | 2 | 2015 | 3312 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4780 | 0.060 |
Why?
|
Alleles | 1 | 2015 | 6893 | 0.060 |
Why?
|
Neoplasms | 4 | 2013 | 22350 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2015 | 619 | 0.050 |
Why?
|
Odds Ratio | 2 | 2013 | 9660 | 0.050 |
Why?
|
Renin | 2 | 2015 | 647 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 1433 | 0.050 |
Why?
|
Pain Measurement | 1 | 2012 | 3584 | 0.050 |
Why?
|
Overweight | 1 | 2013 | 2448 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26325 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5792 | 0.050 |
Why?
|
Laparoscopy | 2 | 2010 | 2037 | 0.050 |
Why?
|
Recovery of Function | 1 | 2012 | 2978 | 0.050 |
Why?
|
Primates | 1 | 2024 | 519 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2647 | 0.050 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2015 | 343 | 0.050 |
Why?
|
Platinum | 1 | 2022 | 219 | 0.050 |
Why?
|
Adolescent | 6 | 2021 | 89046 | 0.040 |
Why?
|
Blood Pressure | 2 | 2014 | 8531 | 0.040 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2020 | 81 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2015 | 4526 | 0.040 |
Why?
|
Pregnancy | 2 | 2020 | 30238 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 790 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7578 | 0.040 |
Why?
|
Risk Factors | 4 | 2014 | 74886 | 0.040 |
Why?
|
Amniotic Fluid | 1 | 2020 | 381 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2014 | 3418 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4210 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12069 | 0.040 |
Why?
|
Symporters | 1 | 2020 | 363 | 0.040 |
Why?
|
Critical Illness | 1 | 2010 | 2753 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2010 | 3797 | 0.030 |
Why?
|
Logistic Models | 1 | 2011 | 13284 | 0.030 |
Why?
|
Child, Preschool | 2 | 2020 | 42606 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.030 |
Why?
|
Europe | 2 | 2013 | 3432 | 0.030 |
Why?
|
Mutant Chimeric Proteins | 1 | 2015 | 19 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16036 | 0.030 |
Why?
|
Steroid 11-beta-Hydroxylase | 1 | 2015 | 20 | 0.030 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2015 | 62 | 0.030 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2015 | 40 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2015 | 65295 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12986 | 0.030 |
Why?
|
Greece | 1 | 2015 | 340 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 20741 | 0.030 |
Why?
|
Fludrocortisone | 1 | 2013 | 24 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5311 | 0.030 |
Why?
|
Education, Nursing | 1 | 2013 | 83 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1217 | 0.030 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2013 | 43 | 0.030 |
Why?
|
Sex Ratio | 1 | 2013 | 107 | 0.030 |
Why?
|
Nursing Assessment | 1 | 2012 | 107 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 5446 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2015 | 385 | 0.020 |
Why?
|
Hospitalization | 1 | 2011 | 10815 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 520 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2014 | 588 | 0.020 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2015 | 627 | 0.020 |
Why?
|
Regression Analysis | 2 | 2012 | 6331 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2015 | 912 | 0.020 |
Why?
|
Self Efficacy | 1 | 2013 | 643 | 0.020 |
Why?
|
Seasons | 1 | 2015 | 1523 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 273 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13650 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2722 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1903 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2012 | 1836 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1345 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2014 | 1804 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2020 | 36582 | 0.020 |
Why?
|
Visual Fields | 1 | 2014 | 1063 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2227 | 0.020 |
Why?
|
Vision Disorders | 1 | 2014 | 1090 | 0.020 |
Why?
|
Animals | 2 | 2024 | 168965 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4114 | 0.020 |
Why?
|
Endosonography | 1 | 2010 | 626 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1253 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9410 | 0.020 |
Why?
|
Pancreatectomy | 1 | 2010 | 825 | 0.020 |
Why?
|
Dexamethasone | 1 | 2013 | 1963 | 0.020 |
Why?
|
Adenoma | 1 | 2015 | 2155 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11872 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2429 | 0.010 |
Why?
|
Cross Infection | 1 | 2012 | 1426 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40154 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15424 | 0.010 |
Why?
|
History, 20th Century | 1 | 2010 | 2765 | 0.010 |
Why?
|
Population Surveillance | 1 | 2012 | 2594 | 0.010 |
Why?
|
Seizures | 1 | 2014 | 2996 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24299 | 0.010 |
Why?
|
Acute Disease | 1 | 2010 | 7236 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4627 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4256 | 0.010 |
Why?
|
Clinical Competence | 1 | 2013 | 4859 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10582 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2011 | 3986 | 0.010 |
Why?
|
Child | 2 | 2015 | 80771 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12823 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13646 | 0.010 |
Why?
|
Survival Analysis | 1 | 2007 | 10092 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27163 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20169 | 0.010 |
Why?
|
Quality of Life | 1 | 2011 | 13485 | 0.010 |
Why?
|